HA-100
HA-100 is a potent protein kinase inhibitor, with IC50s of 4 μM, 8 μM, 12 μM and 240 μM for cGMP-dependent protein kinase (PKG), cAMP-dependent protein kinase (PKA), protein kinase C (PKC) and MLC-kinase, respectively. HA-100 also used as a ROCK inhibitor[1][2].
Product Specifications
CAS Number
84468-24-6
UNSPSC
12352005
Hazard Statement
H315, H319
Target
Myosin; PKA; PKC; ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Epigenetics; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/HA-100.html
Purity
99.87
Solubility
DMSO : 150 mg/mL (ultrasonic; warming)
Smiles
O=S(C1=CC=CC2=C1C=CN=C2)(N3CCNCC3)=O
Molecular Formula
C13H15N3O2S
Molecular Weight
277.34
Precautions
H315, H319
References & Citations
[1]Hagiwara M, et al. Selective modulation of calcium-dependent myosin phosphorylation by novel protein kinase inhibitors, isoquinolinesulfonamide derivatives. Mol Pharmacol. 1987 Jul;32 (1) :7-12.|[2]Yu J, et, al. Efficient feeder-free episomal reprogramming with small molecules. PLoS One. 2011 Mar 1;6 (3) :e17557.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PKC
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
33750116 3x 1.0 µg
Olr1218 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
bsm-60829R-RBITC-01 20 µL
CD34 Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details bsm-60829R-RBITC-02 100 µL
CD34 Recombinant Antibody, RBITC Conjugated
Sign In for Pricing
View Details